Asan Medical Center Myocardial Infarction Registry

Overview

This study evaluates long-term outcome of patients diagnosed as acute myocardial infarction and treated with medication, coronary artery bypass surgery and percutaneous coronary intervention in Asan medical center, Korea.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 31, 2025

Detailed Description

This study will collect 3000 cases retrospectively and 2000 cases prospectively.

Arms, Groups and Cohorts

  • Myocardial infarction
    • diagnosed as acute myocardial infarction and treated with medical treatment, coronary artery bypass surgery and percutaneous coronary intervention.

Clinical Trial Outcome Measures

Primary Measures

  • A composite event of all-cause death, non-fatal myocardial infarction and repeat revascularization
    • Time Frame: 1 year

Secondary Measures

  • All cause death
    • Time Frame: 5 year
  • Cardiac death
    • Time Frame: 5 year
  • Myocardial infarction
    • Time Frame: 5 year
  • A composite event of all-cause death and myocardial infarction
    • Time Frame: 5 year
  • A composite event of cardiac death and myocardial infarction
    • Time Frame: 5 year
  • Repeat revascularization
    • Time Frame: 5 year
  • Stent thrombosis
    • Time Frame: 5 year
    • according to Academic Research Consortium (ARC) criteria
  • Stroke
    • Time Frame: 5 year
    • A stroke or cerebrovascular accident with loss of neurological function caused by an ischemic or hemorrhagic event with residual symptoms at least 24 hours after onset or leading to death.
  • Procedure success
    • Time Frame: 7 days
    • Successful percutaneous coronary intervention at the intended target lesion with final instant residual stenosis of less than 30% by quantitative coronary angiography (QCA) and no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.
  • Surgery success
    • Time Frame: 7 days
    • Successful surgery defines as no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.

Participating in This Clinical Trial

Inclusion Criteria

  • All consecutive acute myocardial infarction patients diagnosed through coronary angiography

Gender Eligibility: All

Minimum Age: 19 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Seung-Jung Park
  • Collaborator
    • CardioVascular Research Foundation, Korea
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Seung-Jung Park, Professor, Division of Cardiology – Asan Medical Center
  • Overall Contact(s)
    • Seung-jung Park, MD, sjpark@amc.seoul.kr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.